| Science and Innovation: The Us Pharmaceutical Industry During the 1980s Contributor(s): Gambardella, Alfonso (Author) |
|
 |
ISBN: 0521451183 ISBN-13: 9780521451185 Publisher: Cambridge University Press OUR PRICE: $123.50 Product Type: Hardcover - Other Formats Published: March 1995 Annotation: This book examines an increasingly important phenomenon for competitiveness and innovation in industry: namely, the growing use of scientific principles in industrial research. Industrial innovation still arises from systematic trial-and-error experiments with many designs and objects, but these experiments are now being guided by a more rational understanding of phenomena. This has important implications for market structure, firm strategies, and competition. Science and innovation focuses on the pharmaceutical industry. It discusses the changes that the notable advances in the life sciences in the 1980s have brought to the strategies of drug companies, the organization of their internal research, their relationships with scientific institutions, the division of labor between large pharmaceutical firms and small research-intensive suppliers, the productivity of drug discovery, and the productivity of R&D. |
| Additional Information |
| BISAC Categories: - Business & Economics | Industries - General - Business & Economics | Economic History - Business & Economics | Labor |
| Dewey: 338.476 |
| LCCN: 95147721 |
| Physical Information: 0.78" H x 6.24" W x 9.28" (1.00 lbs) 216 pages |
| Descriptions, Reviews, Etc. |
| Publisher Description: This book deals with an increasingly important phenomenon for competitiveness and innovation in industry: namely, the growing use of basic scientific principles in industrial research. It focuses on the pharmaceutical industry, and discusses how recent significant developments in molecular biology and genetic engineering are influencing the strategies of drug companies, their organization of internal research, their relationships with scientific institutions, the market structure of the industry, and the productivity of drug research. |